1-7 of 7
Ezio Bombardelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring

Giovanni L. Beretta, Giovanna Petrangolini, Michelandrea De Cesare, Graziella Pratesi, Paola Perego, Stella Tinelli, Monica Tortoreto, Massimo Zucchetti, Roberta Frapolli, Ezia Bello, Carla Manzotti, Gabriele Fontana, Ezio Bombardelli, Arturo Battaglia, Cristian Samorì, Franco Zunino
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10976–10982.
https://doi.org/10.1158/0008-5472.CAN-06-2158
Published: 15 November 2006
View article titled, Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring
Open the PDF for Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring in another window
Journal Articles

Antitumor activity of a new synthetic camptothecin with the open lacton ring.

Graziella Pratesi, Giovanni L. Beretta, Michelandrea De Cesare, Giovanna Petrangolini, Maria Stella Tinelli, Massimo Zucchetti, Roberta Frapolli, Carla Manzotti, Ezio Bombardelli, Franco Zunino
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1301.
Published: 15 April 2006
View article titled, Antitumor activity of a new synthetic camptothecin with the open lacton ring.
Journal Articles

A novel nanoparticle albumin bound thiocolchicine dimer (nab-5404) with dual mechanisms of action on tubulin and topoisomerase-1: evaluation of in vitro and in vivo activity

Ralph J. Bernacki, Jean Veith, Paula Pera, Brian J. Kennedy, Carla Manzotti, Paolo Morazzoni, Ezio Bombardelli, Tapas De, Neil Desai
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 560.
Published: 01 May 2005
View article titled, A novel nanoparticle albumin bound thiocolchicine dimer (nab-5404) with dual mechanisms of action on tubulin and topoisomerase-1: evaluation of in vitro and in vivo activity
Journal Articles

IDN 5390 is a novel seco-taxane derivative with antiangiogenic activity attributable to inhibition of endothelial cell growth and motility

Neeta D. Chaudhary, Rajinder Sawhney, Harry Slocum, Carla Manzotti, Paolo Morazzoni, Ezio Bombardelli, Ralph J. Bernacki
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 945.
Published: 01 April 2004
View article titled, IDN 5390 is a novel seco-taxane derivative with antiangiogenic activity attributable to inhibition of endothelial cell growth and motility
Journal Articles

In vitro cytotoxicity profile of 14-functionalized taxanes.

Ezio Bombardelli, Carla Manzotti, Gabriele Fontana, Antonella Riva, Arturo Battaglia, Maria Luisa Gelmi, Paula Pera, Ralph J. Bernacki, Paolo Morazzoni
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 575.
Published: 01 April 2004
View article titled, <em>In vitro</em> cytotoxicity profile of 14-functionalized taxanes.
Journal Articles

IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity

Maria Ines Nicoletti, Tina Colombo, Cosmo Rossi, Caterina Monardo, Stefania Stura, Massimo Zucchetti, Antonella Riva, Paolo Morazzoni, Maria Benedetta Donati, Ezio Bombardelli, Maurizio D’Incalci, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2000) 60 (4): 842–846.
Published: 01 February 2000
View article titled, IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity
Open the PDF for IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity in another window
Journal Articles

A Novel Taxane with Improved Tolerability and Therapeutic Activity in a Panel of Human Tumor Xenografts

Donatella Polizzi, Graziella Pratesi, Monica Tortoreto, Rosanna Supino, Antonella Riva, Ezio Bombardelli, Franco Zunino
Journal: Cancer Research
Cancer Res (1999) 59 (5): 1036–1040.
Published: 01 March 1999
View article titled, A Novel Taxane with Improved Tolerability and Therapeutic Activity in a Panel of Human Tumor Xenografts
Open the PDF for A Novel Taxane with Improved Tolerability and Therapeutic Activity in a Panel of Human Tumor Xenografts in another window